A recent study has revealed that certain medications used to treat type 2 diabetes may offer protection against dementia and Alzheimer’s disease...
Vous n'êtes pas connecté
TUESDAY, Sept. 3, 2024 -- Sodium-glucose cotransporter-2 (SGLT-2) inhibitors may prevent dementia in middle-aged adults with diabetes, according to a study published online Aug. 28 in The BMJ.Anna Shin, from Seoul National University Bundang...
A recent study has revealed that certain medications used to treat type 2 diabetes may offer protection against dementia and Alzheimer’s disease...
A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower...
A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly lower...
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a newer class of drugs used to manage diabetes, have recently been linked to a rare but serious...
TUESDAY, Sept. 10, 2024 -- Diabetes and prediabetes are associated with accelerated brain aging and potential dementia, according to a study published...
TUESDAY, Sept. 17, 2024 -- Personality traits can influence cardiovascular disease (CVD) risk with type 2 diabetes mellitus (T2DM), according to a...
FRIDAY, Sept. 13, 2024 -- Once-weekly efsitora is noninferior to once-daily degludec for reducing glycated hemoglobin levels in adults with type 2...
TUESDAY, Sept. 17, 2024 -- For postoperative patients with breast cancer, the duration of aromatase inhibitor (AI) treatment is not associated with...
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as...
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as...